Praxis Precision Medicines Financial Statements
NASDAQ: PRAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Praxis Precision Medicines revenue and earnings
In fiscal 2025, Praxis Precision Medicines generated $0 in revenue, down 100.0% from fiscal 2024, the first decline in the 7 years shown. Praxis Precision Medicines reported a net loss of $303.3 million, compared with a loss of $182.8 million a year earlier. Diluted earnings per share came in at -$13.48.
Summary generated from market data by MetaCap's automated system. Methodology
Praxis Precision Medicines income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 8.55M | 2.45M | 0 | — | — | — |
| Revenue growth (YoY) | -100.00% | +249.53% | — | — | — | — | — |
| Operating Expenses | 326.20M | 208.72M | 128.82M | 214.99M | 167.33M | 61.97M | 35.79M |
| Research & Development | 267.12M | 152.41M | 86.77M | 155.04M | 120.26M | 44.98M | 29.56M |
| Operating Income | -326.20M | -200.16M | -126.37M | -214.99M | -167.33M | -61.97M | -35.79M |
| Other Income (Expense) | 22.93M | 17.35M | 3.10M | 957.00K | 271.00K | 140.00K | 193.00K |
| Pretax Income | -302.80M | -182.74M | -123.01M | — | -167.06M | -61.83M | -35.60M |
| Income Tax | 471.00K | — | — | — | 0 | -8.00K | -84.00K |
| Net Income | -303.27M | -182.82M | -123.28M | -214.03M | -167.06M | -61.82M | -35.51M |
| Net Income growth (YoY) | — | — | — | — | — | — | — |
| EPS (Basic) | -13.48 | -10.21 | -18.69 | -69.65 | -3.94 | -7.86 | -26.60 |
| EPS (Diluted) | -13.48 | -10.21 | -18.69 | -69.65 | -3.94 | -7.86 | -26.60 |
| Shares Outstanding (Basic) | 22.50M | 17.91M | 6.59M | 3.07M | 42.45M | 8.95M | 1.53M |
| Shares Outstanding (Diluted) | 22.50M | 17.91M | 6.59M | 3.07M | 42.45M | 8.95M | 1.53M |
| EBITDA | -326.06M | -199.81M | -125.94M | -214.57M | -167.15M | -61.92M | -35.75M |
| Operating Margin | — | -2340.29% | -5164.41% | — | — | — | — |
| Net Margin | — | -2137.48% | -5037.88% | — | — | — | — |
This table shows 7 annual periods of Praxis Precision Medicines's income statement, from FY 2025 back to FY 2019, across 15 line items including revenue, operating expenses, research & development. Values in USD; B = billions, M = millions. Fiscal periods follow PRAX's reporting calendar. What is a income statement?